Jun 17, 2020
ISA Pharmaceuticals Strengthens Strategic Immuno-Oncology Collaboration With Regeneron
Apr 20, 2020
Precigen Announces Clearance of IND to Initiate Phase I/II Study for First-in-Class PRGN-2009 AdenoVerse(TM) Immunotherapy to Treat HPV-positive (HPV+) Solid Tumors
Apr 02, 2020
April is Oral Cancer Awareness Month
Mar 19, 2020
ISA Pharma Publishes Phase 2 Study Data in Major Peer-reviewed Journal
Feb 27, 2020
FDA Grants Breakthrough Therapy Designation for Debiopharm's Novel Chemo-Radio Sensitizer Debio 1143 for Front-line Treatment of Head & Neck Cancer
Dec 03, 2019
QBiotics Announces First Patient Dosed in its Phase I/II Clinical Trial of Tigilanol Tiglate for Head and Neck Cancer
Oct 14, 2019
ISA Pharmaceuticals B.V. Receives EUR 20m Loan From European Investment Bank
Oct 10, 2019
US National Cancer Institute Initiates Phase I Study of Treatment of Head and Neck Cancer Patients With Medivir's Birinapant and Radiation Therapy
Sep 30, 2019
Rakuten Medical Releases New, Post-hoc Analysis of Safety, Pharmacokinetic (PK), Immunogenicity and Biomarker Data from its Phase 1 & 1/2a Clinical Trials
Sep 30, 2019
Global Radiotherapy Market Report 2019-2025 - Significant Opportunities from Developing Economies
Sep 27, 2019
Alpha Tau Medical Appoints Professor Yona Keisari as Chief Scientific Officer
Sep 17, 2019
Aspirin Improves Overall Survival for Patients With Head & Neck, Lung Cancer
Sep 10, 2019
New York's First Proton Therapy Center Begins Treating Patients
Sep 09, 2019
Japan Proton Therapy Market to 2025 by CNS, Head and Neck, Lung, GI , HCC, Pancreas, Gynecologic, Prostate, Bone and Soft Tissue, Others
Aug 28, 2019
Soligenix Announces Positive Recommendation by Independent Data Monitoring Committee on its Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer
Aug 08, 2019
Inovio Pharmaceuticals Reports 2019 Second Quarter Financial Results
Jul 18, 2019
Society for Immunotherapy of Cancer Publishes First Clinical Immunotherapy Treatment Guidelines for Squamous Cell Carcinoma of the Head and Neck
Jun 24, 2019
The global throat cancer therapeutics market at a CAGR of nearly 7% over the forecast period
May 15, 2019
Rakuten Medical Highlights Upcoming Presentations and Activities During the ASCO Annual Meeting, May 31 - June 4, 2019 in Chicago
Apr 08, 2019
Rakuten Medical's ASP-1929 photoimmunotherapy for head and neck cancers to be designated under the Sakigake Designation System for its potential innovativeness and effectiveness